Evidence map›Paper›PMID 41926608›Full record

ArticleJournal of neuropathology and experimental neurology2026

Relationship between promyelocytic leukemia protein nuclear bodies and TAR DNA-binding protein-43 aggregation in spinal anterior horn cells in sporadic amyotrophic lateral sclerosis.

Fumiaki Mori, Tomoya Kon, Riho Itazawa, Ami Akatsu, Yasuo Miki, Akira Arai, Hidekachi Kurotaki, Masahiko Tomiyama, Koichi Wakabayashi

Abstract read
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fumiaki MoriDepartment of Neuropathology, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.ORCID 0000-0003-1903-1766
Tomoya KonDepartment of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.ORCID 0000-0001-6072-3954
Riho ItazawaDepartment of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Ami AkatsuDepartment of Neuropathology, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Yasuo MikiDepartment of Neuropathology, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.ORCID 0000-0001-9375-9590
Akira AraiDepartment of Neurology, Aomori Prefectural Central Hospital, Aomori, Japan.
Hidekachi KurotakiDepartment of Pathology, Aomori Prefectural Central Hospital, Aomori, Japan.
Masahiko TomiyamaDepartment of Neurology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Koichi WakabayashiDepartment of Neuropathology, Biomedical Research Center, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

Funding

JSPS KAKENHI 23K06802JSPS KAKENHI 23K24209JSPS KAKENHI 24K10654JSPS KAKENHI 25K10784JSPS KAKENHI Grant 23K06802 (F.M.), 25K10784 (T.K.), 24K10654 (Y.M.), and 23K24209 (K.W.)
6 · The paper itself

Abstract

Promyelocytic leukemia protein nuclear bodies (PML-NBs) and stress granules serve as deposition sites for stress-induced, aggregation-prone proteins. We previously reported that TAR DNA-binding protein 43 (TDP-43) colocalizes with stress granules during early aggregation in sporadic amyotrophic lateral sclerosis (ALS), and recent studies have noted PML-NB loss in familial ALS. To explore the role of PML-NBs in TDP-43 inclusion maturation, we analyzed spinal cord specimens from 12 patients with sporadic ALS and 5 controls using immunostaining for PML and TDP-43. PML-NB counts in anterior horn cells (AHCs) were significantly lower in patients with ALS than in controls (P < 0.05), especially in AHCs with TDP-43 inclusions (P < 0.01). Average numbers of PML-NB decreased progressively with inclusion type (3.1 in diffuse punctate cytoplasmic staining, 2.3 in round inclusions, and 0.8 in skein-like inclusions); all of these were significantly lower than those in inclusion-free AHCs (controls: 4.6; ALS: 5.5; P < 0.01). AHCs in ALS without inclusions showed higher PML-NB counts than in controls (P < 0.05), suggesting an early protective response. In contrast, reduced PML-NBs in mature inclusions may reflect diminished cellular defense. These findings implicate PML-NBs in the pathogenesis of sporadic ALS.

Indexed as

Amyotrophic Lateral SclerosisAnterior Horn CellsDNA-Binding ProteinsIntranuclear Inclusion BodiesNuclear ProteinsTranscription FactorsTumor Suppressor ProteinsAgedAged, 80 and overFemaleHumansInclusion BodiesMaleMiddle AgedPromyelocytic Leukemia ProteinDNA-Binding ProteinsNuclear ProteinsPML protein, humanPromyelocytic Leukemia ProteinTARDBP protein, humanTranscription FactorsTumor Suppressor Proteinsanterior horn cellnuclear bodyPMLsporadic amyotrophic lateral sclerosisTDP-43 inclusion

Identifiers

PMID41926608
PMCPMC13440670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.